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THE finding that 8-methoxy-3: 4-benzpyrene is one of the most active
carcinogens for mice and rats (Cook and Schoental, 1952b; Peacock and Head,
1952) stimulated interest in other methoxy-derivatives ofpolycyclic hydrocarbons.
Isomers having the methoxy-group at the more hindered position of the phen-
anthrenoid bond known as the "K region" seemed of particular interest, as
3-methoxy-1 : 2-benzanthracene has been found to be slightly carcinogenic
(Shear and Leiter, 1940). The "K region" may possibly be involved in the
metabolic fate of the hydrocarbons (Bhargava, Hadler and Heidelberger, 1955).
A convenient route for the preparation of these compounds is the osmium
tetroxide oxidation of the respective hydrocarbons (Cook and Schoental, 1948)
in the presence ofpyridine. Hydrolysis ofthe complexes yields diols, which under
the influence of dilute mineral acids undergo dehydration to phenols, methylation
ofwhichresults inthe respective methyl ethers. Inthe case of1: 2: 5: 6-dibenzan-
thracene dehydration of the diol and subsequent methylation yields 3-methoxy-
1: 2: 5: 6-dibenzanthracene(I), and only traces of a second isomer. In the
case of 3: 4-benzpyrene two products were obtained, one melting at 136-7° C.,
the other at 179.5-180° C. Although their respective identity has not yet been
proved by independent synthesis, the lower melting compound is likely to be
the 7-methoxy-3: 4-benzpyrene (II), and the higher melting isomer 6-methoxy-
3: 4-benzpyrene(II). Melting points of isomers having a bulky substituent (such
as a methoxy-group) at a hindered position are usually lower than the ones
substituted at an unhindered position. The compound melting at 136-7° C. was
used for biological testing.
In view of the carcinogenic activity of 5-alkyl-1 : 2-benzanthracenes (Barry
et al., 1935) 5-methoxy-1 : 2-benzanthracene (III) (synthesised by Cook and
Schoental, 1952a) was also tested.
I II III
3-Methoxy-1: 2: 5: 6-dibenzanthracene. 7- (or6-) Methoxy-3: 4-benzpyrene. 5-Methoxy-1: 2-benzanthracene.
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EXPERIMENTAL.
Mice of mixed stock, bred in the Departmental Animal House, were used. The
animals were housed in metal cages, 5-6 per cage, andgiven Shearer's Pig Weaner
Nuts No. 1 (for their composition see Schoental, Head and Peacock, 1954) and
tap water ad libitum.
I. 3-Methoxy-1 : 2 : 5: 6-dibenzanthracene.--Pure crystalline 3-methoxy-1 : 2 : 5: 6
dibenzanthracene was dissolved in tricaprylin and injected subcutaneously into
the left flank of 12 male and 12 female mice, about 6 weeks old; each animal
receiving 0.5 mg/0.1 tricaprylin.
II. 7 (or 6)-Methoxy-3: 4-benzpyrene.-Five male and 10 female mice about 6
weeks old eachreceived a single subcutaneous injection of0.5 mg. 7 (or 6)-methoxy--
3: 4-benzpyrene in 0.1 ml. oftricaprylin.
III. 5-Methoxy-1: 2-benzanthracene. Seven male and 10 female mice about 1-2
months old each received a single subcutaneous injection of 1.5 mg. of pure
5-methoxy-1: 2-benzanthracene in 0.15 ml. of tricaprylin.
The animals were allowed to live as long as possible: some were killed when
moribund. All mice were examined post morterm, and the tumours and other
observed abnormalities confirmed by histological examination. For this purpose
selected tissues were fixed in formol-corrosive, and stained with haematoxylin
and eosin. In addition other stains were used in cases requiring further
differentiation.
RESULTS.
I. 3-Methoxy-1: 2: 5: 6-dibenzanthracene.
No tumours were found at the site of injection in any of the 24 mice injected
with 3-methoxy-1:2: 5: 6-dibenzanthracene, although 9 mice survived over 22
months after the injection, and the oily solution remained palpable as a definite
nodule under the skin for several months. Lung adenomata were found in 5
females and 2 males. In the livers of 2 female mice (one ofwhich had lung adeno-
mata) hepatomata were present.
II. 7 (or 6)-Methoxy-3 : 4-benzpyrene.
The first tumour at the site ofinjection with 7 (or 6)-methoxy-3 : 4-benzpyrene
was noticed in a male mouse 6 months after the injection. The animal was killed
one month later, when the tumour measured 3.7 x 1-8 cm. It was partly haemor-
rhagic, and partly white and fleshy, and was invading the muscle. No metastases
were present. Microscopically the tumour was a pleomorphic sarcoma, composed
of round and spindle cells. Some strap-like cells were seen which stained yellow
by van Gieson's method. They contained large nuclei, but no muscle striations
couldbe demonstrated in sections stainedwithphosphotungstic acid,haematoxylin,
Heidenhain's iron haematoxylin or Celestial Blue. In places many giant cellswere
noted and mitoses were numerous. The tumour was seen invading muscle. Among
the remaining 4 male mice one had lung adenomata, one had a tumour ofthe thy-
mus and one lymphomatosis.
Among the female mice, 3 developed tumours at the site of injection after 6,
11 and 14 months respectively. On microscopic examination these proved to be
sarcomata of the spindle cell type.
No neoplastic changes were found in the remaining 7 females and 1 male.
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III. 5-Methoxy-1: 2-benzanthracene.
In 5 of the 17 mice, 4 females and 1 male, tumours developed at the site of
injection of 5-methoxy-1 : 2-benzanthracene. The first tumour appeared about 16
months after the injection in a female mouse. The animal was killed about 3
weeks later, and had a white fleshy tumour 1.5 x 1 cm. on the left side ofthe back,
invading muscle. Microscopically it proved to be a spindle cell sarcoma in which
numerous giant cells were present. Many cells were in mitosis. In the liver ofthis
animalsome zonal degeneration andregeneration werepresent. In theregenerating
areas mitoses were seen in a number of cells. Similar tumours, spindle cell sarco-
mata, were present in 3 other female mice killed 17 months, 21-5 months and 24
months after the injection, respectively. Lung adenomata were found in one
tumour-bearing mouse killed 17 months after the injection, as well as in one female
mouse which died 25 months after the injection and which had no local tumours.
Among the 7 male mice of this series only one was found to have a tumour
2.4 x 2.4 cm. at the site ofinjection when the animal was killed after 21 months.
On microscopic examination the tumour proved to be a spindle cell sarcoma
invading muscle. In theliver ofthis animal ahepatoma containing manyeosinophil
cytoplasmic inclusions was present in the upper part of the central lobe.
No tumours were found in the remaining 12 animals of this series.
DISCUSSION.
It is of interest that 3-methoxy-1: 2: 5: 6-dibenzanthracene did not produce
any tumours as carcinogenic activity has been demonstrated in the case of
3-methoxy-1: 2-benzanthracene (Shear and Leiter, 1940). No such difference was
shown by methoxy-derivatives ofthese two hydrocarbons, having the substituent
at the meso-position. Thus both 9-methoxy-1: 2: 5: 6-dibenzanthracene and
10-methoxy-1I: 2-benzanthracene produced tumours in mice: the former when
tested by repeated subcutasneous injections (Shear and Leiter, 1940), the latter by
applications to the skin of a 0.3 per cent, solution in benzene (Barry et al., 1935).
7 (or 6)-methoxy-3: 4-benzpyrene produced sarcomata in 4 out of 15 animals,
6-15 months after the injection. Thus, this isomer is a less potent carcinogen than
8-methoxy-3: 4-benzpyrene, which gave tumours in 8 out of 16 mice 10-14 weeks
after subcutaneous injection ofa similar dose. Its activity is comparable with that
of 5-methoxy-3: 4-benzpyrene, which produced tumours in 2 out of 10 mice after
subcutaneous injection in the course of 12 months (Berenblum and Schoental,
1944).
5-Methoxy-1: 2-benzanthracene gave rise to 5 sarcomata in 17 mice; the
tumours appearing 16-24 months after the subcutaneous injection. This long
latent periodindicatesthatthis compoundis aweakcarcinogen; the corresponding
5-methyl-1: 2-benzanthracene produced 5 epitheliomata and 2 papillomata in
10 mice receiving skin applications of a 0.3 per cent solution in benzene twice
weekly (Barry et al., 1935) in an experiment lasting 433 days.
No significance can be attached to the occurrence of lung adenomata or liver
tumours in the experimental animals. A fairly high incidence of these tumours,
especially oflung adenomata, having been encountered among control mice ofthe
mixed strain used.
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